Cost –effectiveness of pembrolizumab versus chemotherapy as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in USA

Immunotherapy, Ahead of Print.

Source: Immunotherapy - November 17, 2019 Category: Allergy & Immunology Authors: Min Huang Gilberto de Lima Lopes Ralph P Insinga Thomas Burke Flavia Ejzykowicz Ying Zhang Josephine L Feliciano Source Type: research